QCI Interpret

Visit us at AMP to discover how we’ve standardized and automated your somatic variant interpretation and reporting with AMP/ASCO/CAP guidelines.

QCI Interpret, now integrated with 2017 AMP/ASCO/CAP guidelines for somatic testing and a new somatic report, delivers the highest quantity and quality of clinical evidence to support therapeutic decision-making.QCI Interpret, now integrated with 2017 AMP/ASCO/CAP guidelines for somatic testing and a new somatic report, delivers the highest quantity and quality of clinical evidence to support therapeutic decision-making.

  • Automated to give actionable results more economically and efficiently
  • Continuously updated for ready access to the most current clinical evidence
  • Backed by decades of experience and expertise of hundreds of MDs and PhDs

register for a demo

See how QCI Interpret enables rapid implementation or scaling of somatic testing services (and hereditary testing too!)

 

QCI Interpret is an evidence-based decision support software intended as an aid in the interpretation of variants observed in genomic sequencing data. The software evaluates genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and clinical-trials. Based on this evaluation, the software proposes a classification to aid in the interpretation of observed variants. The software is NOT intended as a primary diagnostic tool by physicians or to be used as a substitute for professional healthcare advice. Each laboratory is responsible for ensuring compliance with applicable international, national, and local clinical laboratory regulations and other specific accreditations requirements.

Related

Visit us at AMP 2017, Booth #707

Register for a demo
Social Sharing